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An algorithm for the treatment of the biliary
complications of hepatic hydatid disease
Aim: The treatment of hepatic hydatid disease (HHD) is currently standardized. Biliary complications
of HHD complicate both the treatment and course of the disease. Several investigations have been
performed on the biliary complications of HHD and their treatment. We propose an algorithm for
the treatment of the biliary complications of HHD based on our experience.
Materials and methods: We investigated 148 patients that underwent endoscopic retrograde
cholangiopancreatography (ERCP) due to complicated HHD between January 2000 and December
2006 at the endoscopy unit of the Department of Surgery of Atatürk University Medical School. Age,
sex, indications for ERCP and endoscopic sphincterotomy (ES), ERCP findings, laboratory data,
operative findings, postoperative complications, and additional interventions (surgical or
percutaneous) were noted.
Results: Twenty-six patients had not previously undergone surgery for HHD. While 23 of these
patients underwent ERCP preoperatively, 3 underwent ERCP during both the pre- and postoperative
periods. The remaining 122 patients underwent surgery for HHD and ERCP during the postoperative
period.
Indications for preoperative ERCP were cholangitis and various clinical signs of cysto-biliary
communication (CBC), such as abnormal liver function test results (bilirubin, ALT, AST, GGT, and
ALP), biliary colic, and obstructive jaundice. In this group of patients ERCP/ES was not successful in
2 patients that underwent surgery due to emergent circumstances, and another 3 patients developed
postoperative biliary fistulae.
Indications for postoperative ERCP were persistent bile leakage after surgical treatment for HHD,
postoperative hyperbilirubinemia and cholangitis, and postoperative biloma formation in the cystic
cavity. All patients with cholangitis experienced relief of symptoms after ERCP and ES, 1 patient with
biloma formation and 5 patients with persistent biliary fistulae were operated on.
Conclusion: ERCP and ES are highly effective in the treatment of the biliary complications of HHD.
Repeat ERCP should be performed in patients that do not respond to the first intervention.
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Karaciğer hidatik hastalığının biliyer komplikasyonlarının
tedavisi için bir algoritma
Amaç: Karaciğer hidatik hastalığının (KHH) tedavisi artık standardize edilmiştir. KHH’nın safra
yolunda oluşturduğu komplikasyonlar hem tedaviyi hem de hastalığın seyrini komplike hale
getirmektedir. KHH’nın biliyer komplikasyonları ve tedavisi hakkında çok sayıda çalışmalar
yapılmıştır. Biz bu çalışmada KHH’nın biliyer komplikasyonlarının tedavisi üzerine kendi
deneyimlerimize dayalı bir algoritma öne sürdük.
Yöntem ve gereçler: Ocak 2000 ile Aralık 2006 tarihleri arasında Atatürk Üniversitesi Tıp Fakültesi
Genel Cerrahi AD, Endoskopi Ünitesinde 148 hastaya komplike KHH için endoskopik retrograd
kolanjio- pankreatografi (ERKP) yapıldı. Hastaların yaşları, cinsiyetleri, ERKP ve endoskopik
sfinkterotomi (ES) endikasyonları, laboratuar verileri, ameliyat bulguları, ameliyat sonrası
komplikasyonlar ve başka girişimler (cerrahi veya perkütan) kaydedildi.
Bulgular: Yirmi altı hasta daha önceden KHH için ameliyat olmamıştı. Bunları 23’üne ameliyattan
önce 3’üne ise hem ameliyattan önce hem de ameliyattan sonra ERKP yapıldı. Geri kalan 122 hasta
ise KHH nedeniyle ameliyat edilmiş hastalardı ve bunlara ameliyattan sonraki dönemde ERKP yapıldı.
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Ameliyat öncesi dönemde ERKP endikasyonları kolanjit ve kisto-biliyer iştirake ait, karaciğer
fonksiyon testlerinde (bilirubin, ALT, AST, GGT, ALP) anormallikler, biliyer kolik ve tıkanma sarılığı
gibi klinik bulguların varlığıydı. Bu grupta 2 hastada ERCP/ES başarılı olmadı ve bu hastalar acil
şartlarda ameliyat edildi ve başka 3 hastada ameliyattan sonra safra fistülü gelişti.
Ameliyat sonrası dönemde ERKP için endikasyonlar KHH’nın cerrahi tedavisinden sonra persistan
safra fistülü, ameliyat sonrası bilirubin yükselmesi ve kolanjit ve kist boşluğunda ameliyat sonrasında
biloma oluşmasıydı. Kolanjitli tüm hastalarda ERKP ve ES sonrası semptomlar geriledi, bilomalı bir
hasta ve persistan safra fistülü olan 5 hasta ameliyat edildi.
Sonuç: Biz KHH’nın biliyer komplikasyonlarının tedavisinde ERKP ve ES’nin çok etkili olduğu
sonucuna vardık. İlk girişime cevap vermeyen hastalarda ERKP tekrar edilmelidir.
Anahtar sözcükler: Karaciğer hidatik kist hastalığı, persistan safra kaçağı, biloma, ERKP

Introduction
Hydatid disease is endemic in many parts of the
world. The disease most commonly affects the liver,
and treatment of hepatic hydatid disease (HHD) is
currently standardized. While surgery is the mainstay
of radical treatment and has the potential for a
complete cure, other treatments, such as PAIR
(puncture, aspiration, injection, and re-aspiration)
and chemotherapy with benzimidazole compounds,
have limited utility. Depending on the individual case,
each of these therapeutic modalities has potential as
well as limitations of varying degrees. Although
chemotherapy is a noninvasive treatment, its success
is limited as a single measure, and thus it is used in
addition to other therapeutic modalities (1).
Complications of HHD are primarily the result of
its effect on the biliary tree. Indeed, biliary rupture is
one of the most common complications and can vary
between small cysto-biliary communication (CBC) to
large intrabiliary rupture (2). Biliary rupture can
complicate the course of the disease, during both the
pre- and postoperative periods. Preoperatively, biliary
obstruction can cause cholangitis and obstructive
jaundice. During the postoperative period it can cause
biliary fistulae, which can be difficult to manage.
Therapeutic
endoscopic
retrograde
cholangiopancreatography (ERCP), including
endoscopic sphincterotomy (ES), and balloon and
basket extraction, are the first choices of treatment in
patients with biliary complications of HHD. In the
present study we report our experience with the use of
ERCP in the treatment of HHD and define an
algorithm for the treatment of HHD with biliary
complications.
672

Materials and methods
We used data obtained from 148 patients that
underwent ERCP for complicated HHD between
January 2000 and December 2006 at the endoscopy
unit of the Department of Surgery of Atatürk
University Medical School. Age, sex, indications for
ERCP and ES, ERCP findings (contents of the CBD,
communication with the cystic cavity), and laboratory
data (bilirubin, alanine amino transferase [ALT],
aspartate amino transferase [AST], gamma-glutamyl
transferase [GGT], and alkaline phosphatase [ALP]
levels, operative findings, postoperative complications
[duration and amount of biliary drainage] and
additional interventions [surgical or percutaneous])
were noted. Indications for ERCP and ES were
described as laboratory findings that indicated CBC
preoperatively, preoperative biliary complications
(cholangitis, obstructive jaundice), postoperative
persistent biliary leakage, and biloma and cholangitis.
Postoperative persistent bile leakage was described as
continuous bile discharge from a lodge drain for more
than 10 days (3).
Study patients were kept nil per os (NPO) during
the night before the procedure. While in the prone
position patients were intravenously administered
sedative premedication, which consisted of
midazolam 0.05 mg kg−1 and pethidine HCl 0.5 mg
kg−1; these patients were closely monitored via pulse
oximetry.
ERCP was performed with therapeutic endoscopes
(Olympus TJF 240, Tokyo, Japan), using standard
ERCP catheters and sphincterotomes. A balloonoccluded cholangiogram was obtained to demonstrate
subtle communication when communication was not
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observed with routine cholangiography. ES, followed
by the extraction of the cyst membrane or daughter
cysts, was performed as indicated. All patients that
underwent surgery in our clinic received preoperative
−1
albendazole treatment (10 mg kg ) 15 days before the
operation and 2 months postoperatively (according to
the surgeon’s preferences). The decision to perform
ERCP or ES, pre- or postoperatively, was also made
according to the surgeon’s preferences. Operative
procedures were also chosen by the surgeon.
Surgeons from other hospitals were invited to
share their data and report their patients’
complications and outcomes during the follow-up
period. The duration of the follow-up period was
between 6 and 70 months. In all, 126 patients were
followed-up at our clinic and 22 were followed by
surgeons at other hospitals. Follow-up data were
obtained from 117 patients.
The data were analyzed using SPSS v.12.0 (SPSS,
Chicago, IL, USA). Analysis was performed using
Student’s t test for continuous variables, and chisquare or Fisher exact tests for categorical variables.
Pearson’s correlation analysis was used to determine
the correlations between the duration of fistulae, and
the daily output and timing of ERCP, between the size
of the cysts and closure time, between the size of the
cysts and daily bile output, and between the amount of
daily output and duration of closure. P < 0.05 was
considered statistically significant.
Results
In total, 148 patients that underwent ERCP and ES
for complicated HHD between January 2000 and
December 2006 at the endoscopy unit of the
Department of Surgery of Atatürk University Medical
School were included in the study. During this period
1532 ERCPs were performed in our endoscopy unit;
26 of the patients had not previously undergone
surgery for HHD. While 23 of the patients underwent
ERCP preoperatively, 3 underwent ERCP during both
the pre- and postoperative periods. The remaining
122 patients had surgery for HHD and underwent
ERCP during the postoperative period.
Preoperative ERCP
Nine patients underwent preoperative ERCP and
ES for the treatment of cholangitis. In the remaining
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17 patients ERCP and ES were performed to address
various clinical signs of CBC, such as abnormal liver
function test results (bilirubin, ALT, AST, GGT, and
ALP), biliary colic, and obstructive jaundice. Mean
age of patients that underwent preoperative ERCP was
35.6 years (range: 12-67 years). Twenty patients had 1
cyst and the other 6 patients had 2 cysts (total: 32
cysts). Mean diameter of the cysts was 8.3 ± 4.1 cm
(range: 3-16 cm). Twenty of the cysts had a diameter
larger than 10 cm, and 22 cysts were located on the
right lobe and the remaining 10 were located on the
left lobe. Twelve cysts were located on the caudate
lobe, and segments 4 and 5.
All patients in the preoperative ERCP group
underwent ERCP and ES. Successful cannulation of
the common bile duct was initially performed in 22
patients, followed by another 4 patients. The diameter
of the common bile duct (CBD) ranged from 6 to 38
mm. There were no positive findings in 4 of the
patients. In 2 of the patients the CBD was compressed
and distorted by the cysts. In the remaining 20
patients cystic contents, germinative membranes, and
purulent material were drained from the CBD.
Additionally, 4 of the patients underwent a second
ERCP (3 with cholangitis, 1 with obstructive
jaundice). In 24 patients symptoms resolved after the
first or second endoscopic intervention. In 2 of the
patients with cholangitis, the clinical signs did not
resolve and they were operated on under emergency
circumstances.
All patients in this group were operated on (24
elective and 2 emergency). Eight patients had infected
cystic contents and bile in their cysts. Cystic cavities
were explored for possible bile duct openings, and in
4 patients openings were found and sutured (Figure
1). In the patients that underwent emergency surgery,
CBD exploration was performed during the
procedure, in addition to the management of the cyst
and
cystic
cavity
(Figure
2).
A
choledocoduodenostomy was also performed in the
2 patients that were operated on under emergency
conditions.
Overall, persistent postoperative bile leakage
developed in 3 (11.5%) of these patients.
Postoperative ERCP
In total, 125 patients underwent ERCP during the
postoperative period (including 3 patients that
673
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abdomen. Mean CBD diameter at the time of ERCP
was 12.2 mm (range: 8-21 mm). ERCP demonstrated
CBC in 2 patients (Figure 3) and choledocholithiasis
(extracted with balloon catheter) in 1 patient. The
remaining patients had purulent material in the CBD,
which was promptly drained. ES was performed in all
of these patients. In all patients the signs and
symptoms of cholangitis resolved after ERCP and ES,
without the need for additional ERCP/ES or surgery.
There was rapid relief of symptoms, within a mean of
1.2 days (range: 1-4 days).

Figure 2. Intraoperative photo shows hydatid membrane
extraction from the common bile duct.

Figure 3. ERCP image shows communication between the bile
duct and cystic cavity.

Figure 1. Intraoperative demonstration of communication
between the cystic cavity and the bile duct. Arrow
indicates the tip of the boogie introduced from the CBC
into the CBD.

underwent preoperative ERCP at our clinic).
Persistent bile leakage after surgical treatment for
HHD
in
99
patients,
postoperative
hyperbilirubinemia and cholangitis in 12 patients, and
postoperative biloma formation in the cystic cavity in
14 patients were the indications for postoperative
ERCP.
Postoperative cholangitis
Twelve patients underwent ERCP and ES for
postoperative cholangitis. All had elevated liver
function test results, hyperbilirubinemia, fever, and
leukocytosis. There were no signs of biliary leakage or
bile accumulation in the cyst cavity or in the

674

Postoperative biloma
Fourteen patients underwent ERCP and ES for
bilomas in the cystic cavity. In 10 of the patients
percutaneous drainage of the cavity, prior to ERCP,
was performed. In 4 of the patients, percutaneous
drainage was not technically possible because of the
localization of the cyst. In all, 5 patients underwent
repeat ERCP/ES.
Mean CBD diameter at the time of ERCP was 13.4
mm (range: 8-19 mm). ERCP demonstrated CBC in 8
of the patients. In 6 of the patients there were no
positive findings at the time of ERCP.
In 13 patients ERCP/ES alone, or in combination
with percutaneous drainage, was effective and the
bilomas completely resolved. (Figures 4-6) In 1 patient
(who was percutaneously drained) the biloma did not
resolve and a cavity infection developed. This patient
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Figure 4. Axial CT scan shows the formation of a large biloma in
the operated cystic cavity on the right lobe of the liver.

Figure 5. Axial CT scan shows a biloma drained percutaneously.

then underwent a right hepatectomy. Mean time of
cyst resolution was 21 ± 12 days (range: 6-39 days).
Postoperative biliary leakage
Ninety-nine patients with persistent bile leakage
after surgical treatment for HHD underwent
ERCP/ES. Of these patients, 77 were operated on at
our clinic and 22 were operated on at different clinics,
but were referred to our department for additional
interventions. Four patients had 3 cysts, 12 had 2
cysts, and 83 had only 1 cyst (total cysts: 119). Mean
cyst diameter in this group was 8.6 ± 6.1 cm. In 57
(57.5%) of the patients the cyst associated with bile
leakage was larger than 10 cm. There was a positive
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Figure 6. Axial CT scan shows a collapsed cystic cavity after
drainage of the biloma within the cavity.

correlation between the size of the cyst and closure
time (P = 0.04, r = 0.4). There was no correlation
between the size of the cyst and daily bile output (P <
0.05). Of the 119 cysts, 18 (15.1%) were located on the
left liver lobe and 101 (84.9%) on the right liver lobe.
Twenty-two of the patients in this group had not
received albendazole pre-treatment (13 were operated
on at another clinic, 2 were pregnant, and 7 were
allergenic to albendazole). Four patients were
operated on in an emergency setting due to a free
intraperitoneal rupture. Forty-four of the cysts
contained infected material and bile, while the
remaining cysts were free of these contents. CBC was
demonstrated in 19 (19.1%) of the cysts, which were
sutured intraoperatively.
During the postoperative period 57 patients
(57.5%) had elevated ALP and GGT levels, 21 patients
(21.1%) had, in addition, elevated ALT, AST, and
bilirubin levels. The remaining 42 patients (42.4%)
had normal levels of ALP, AST, ALT, GGT, and
bilirubin.
Biliary drainage began on the 1st day in 49 of the
patients (49.4%), on the 2nd day in 30 patients
(30.3%), and on the 3rd day in 20 patients (21.3%).
Mean drainage was 475 ± 215 cc (range: 80-1400 cc).
There was a positive correlation between the daily
output and closure time (P = 0.01, r = 0.04). ERCP
was performed between the 8th and 47th
postoperative days, with a mean of 17.2 days. In 38
patients (38.3%) ERCP/ES was performed within 20
675
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days postoperatively, and in the remaining 61 patients
(61.7%) it was performed after the 20th postoperative
day. All patients underwent ES. There was a positive
correlation between the timing of the ERCP and
duration of closure (P = 0.01, r = 0.2). Selective CBD
catheterization was successful in 79 (79.8%) patients
during a first attempt and in 20 patients during a
second attempt. Two patients had periampullary
diverticula.

hydatid disease, 3 for obstructive jaundice, 3 for
cholangitis, 1 for liver abscess, and 1 for persistent
pain at the operation site (right upper quadrant).

Mean CBD diameter was 14.2 ± 5.4 mm (range: 628 mm). In 85 patients (85.8%) there were cystic
contents, purulent material, infected bile, or sludge in
the CBD, which was extracted after ES. One patient
had choledocholithiasis, which was also extracted. In
13 (13.1%) patients the CBD was less than 8 mm in
diameter and was empty. CBC was observed in 79
(79.7%) of the patients.

Three patients with recurrent hydatidosis were
treated percutaneously and the other 2 were operated
on. None of these patients had repeat ERCP/ES.

Of the patients with postoperative biliary fistulae,
94 benefitted from ERCP/ES (94.9%). Twenty-one
patients required a second ERCP/ES and 9 required a
third ERCP/ES. In all patients with postoperative
biliary fistulae, daily fistula output decreased after the
1st, 2nd, or 3rd endoscopic intervention; however,
biliary drainage did not end in 5 of the patients. The
time between the first and second ERCP varied
between 11 and 21 days (mean: 13.1 days). A decrease
in biliary drainage after ERCP and ES was evident
after 2.4 days (range: 1- 18 days); biliary drainage
ended in a mean of 5.2 days (range: 2-57 days).
Five patients were re-operated on for persistent
biliary fistulae after the first operation. One patient
received a cystojejunostomy, 1 received a right
hepatectomy, and 3 received a pericystectomy.
Complications
The overall complication rate was 0.4% (6
patients). One patient suffered from bleeding related
to ES, 4 patients had pancreatitis, and 1 developed
cholangitis after ERCP and ES. There were no
perforations related to ERCP or ES among the 148
patients. In 16 patients transient elevated amylase, not
associated with pancreatitis, was observed.
Follow-up period
We were able to collect follow-up data from 79
(53.3%) of the 148 patients. Mean follow-up period
was 31.3 months (range: 12-84 months). Fourteen
patients were readmitted to our clinic: 5 for recurrent
676

There were no positive findings in the patient with
persistent pain and no treatment was given. The
patient with liver abscess at the residual cavity was
treated with percutaneous drainage and repeat ERCP
and ES. The hepatic abscess resolved 14 days after the
ERCP/ES.

All of the patients with cholangitis and obstructive
jaundice underwent repeat ERCP/ES. There was no
CBC in these patients. Purulent material and sludge
were drained from the CBD in patients with
cholangitis, as well as from 2 patients with obstructive
jaundice. One patient with obstructive jaundice had
a deformed and twisted CBD. This patient was treated
with biliary stenting and bilio-enteric diversion
(hepaticojejunostomy).
Discussion
CBC, communication between the cyst and the
biliary tree, is classified as major and minor (4). It is
also defined as an intrabiliary rupture and is among
the most common complications of hydatid cysts of
the liver. Major (or frank) rupture is defined as cystic
contents draining directly into a major biliary duct,
causing intermittent or complete obstruction of the
duct, thereby causing symptoms and laboratory
abnormalities. Minor (occult or simple) ruptures can
be asymptomatic and can become postoperative biliocutaneous fistulae, unless they are properly sutured at
the time of surgery (5). While the true incidence rate
of CBC is unknown, several studies report incidence
rates between 5% and 37%. The incidence rate of
frank intrabiliary rupture is reported to range between
5% and 17% (2,6-15). The criteria for CBC are
visualization of a cysto-biliary opening during surgery
or demonstration of communication by ERCP in
patients with hydatid jaundice or biliary leakage after
hydatid surgery of the liver (16).
It is reported that pressure within the hydatid cyst
that is higher than the bile pressure, fragility of the
parasitic wall, and proximity of the cyst to a major
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biliary duct are the main factors responsible for
rupture of the cyst into the biliary tree (5).
CBC complicates the treatment of HHD. During
the preoperative period CBC can cause infection of
the cyst, thereby forming an infected cyst and abscess.
Drainage of the cystic contents into the biliary tree
then causes obstructive jaundice and even cholangitis.
During the postoperative period the main problem is
bile leakage or bile fistulae. Biliary fistulae develop
when the postoperative leak is able to drain; if not,
biliary peritonitis and biliary abscesses develop (16).
In the present study we experienced the
therapeutic use of ERCP in preoperative settings, but
preoperative ERCP has both diagnostic and
therapeutic uses. The use of ERCP in all patients with
HHD, including asymptomatic patients, remains
controversial because there are limitations to the
diagnostic utility of ERCP in this setting. It is reported
that due to increased pressure within the cyst,
minimal extent of communication, or transient
obstruction of the aperture from a superimposed
daughter cyst, small CBCs cannot be seen in some
cases. Moreover, on rare occasions an intrahepatic
biliary tree may not be filled because of the extrinsic
mass effect of the hydatid cyst at the hilum of the liver.
Indeed, the false-negative rate of this condition may
be as high as 17%-20% (17,18). Ozaslan et al. (2)
reported that daughter cysts, or hydatid material
within the common bile duct, may not always be
detected (2). Yet another important issue is
complications of ERCP. Although complication rates
are reported to be low, these rates are expected to rise
due to the known inherent risks of therapeutic ERCP
procedures (19). Despite these limitations, it is
reported that in 25%-50% of asymptomatic patients
ERCP can identify features compatible with CBC (17).
We used ERCP to preoperatively treat
complications in patients with HHD. All patients were
symptomatic and had elevated liver enzymes, and the
indications were cholangitis, obstructive jaundice, and
biliary colic. The use of preoperative ERCP is mostly
recommended in symptomatic patients (2,17,20,21).
CBC and obstruction due to daughter cysts or hydatid
material detected during cholangiography can be
managed by preoperative therapeutic ERCP,
including sphincterotomy, balloon and basket
extraction, nasobiliary drainage (NBD), or stent
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insertion; the success rate is reported to be between
80% and 100% (4,10,22-32). Other researchers
suggest the use of stents or NBD during the
preoperative period, just for symptom relief and
avoidance of postoperative biliary fistulae (2,33). It is
proposed that in some cases (up to 25% in some
series) there is no need for elective surgical treatment
after endoscopic intervention. Moreover, insertion of
an NBD and irrigation of the cystic cavity with
hypertonic saline are suggested (21,34); however, we
did not use NBD and did not experience spontaneous
cyst resolution.
In the presented series preoperative ERCP and ES
failed in 2 patients with cholangitis, despite repeat
ERCP. These 2 patients underwent emergency surgery
and CBD exploration was performed. The remaining
patients underwent elective ERCP and ES.
Preoperative ES in order to avoid postoperative
external fistulae is also recommended. Rodriguez et
al. (28) reported that none of their patients developed
postoperative persistent fistulae after preoperative
sphincterotomy (8 cases) (28); however, 3 (11.5%) of
our 26 preoperative ERCP patients developed
persistent biliary fistulae following elective surgery
and postoperatively underwent repeat ERCP/ES.
Thus, the cystic cavity should be examined for biliary
openings, even if preoperative ES is performed.
How can the risk of biliary leakage from CBCs be
evaluated preoperatively, and what should be done
intraoperatively? In order to reduce postoperative bile
leaks, all efforts should be made, both preoperatively
and during surgery, to detect CBCs. An intraoperative
cholangiogram may also be useful (16,35). This
intraoperative cholangiogram could be made via a ttube or a preoperatively placed NBD during the
operation (35). While a choledochotomy for
placement of a t-tube seems invasive, a less invasive
procedure could be to place an NBD prior to surgery,
as this could be used to perform a cholangiogram
during and after the operation. Indeed, it can be useful
during the operation for detecting small CBCs. Yet the
placement of an NBD is not entirely harmless, as it is
uncomfortable for the patient and has the potential
for stricture formation.
Postoperative complications for patients with
HHD include the formation of bilomas, cholangitis,
and persistent biliary leakage. Cholangitis may
677
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develop after HHD surgery and can be present in 11%
of patients that develop biliary fistulae after HHD
surgery (5). Lee et al. (36) compared the use of a stent
and NBD for the early decompression of the CBD in
acute cholangitis. While they found that the 2
methods were equally effective, they reported that
NBD was less comfortable (36). In 12 of our patients
ERCP and ES were performed for the treatment of
cholangitis. The efficacy of ERCP and ES in these
patients was high, and there was no need for further
surgical or endoscopic treatment.
Another complication is postoperative biloma
formation. In 14 patients we observed bilomas at the
residual cavity of the HHD. This occurs when there is
CBC and the cavity is not properly drained. ERCP and
ES were performed for the management of this
condition. Percutaneous drainage was performed in
10 patients that were suitable for this approach.
Christoforidis et al. (37) investigated the use
ERCP/ES, and stent and NBD insertion combined
with percutaneous treatment in post-cholecystectomy
bilomas and reported that it was effective (37). In the
present study ERCP and ES alone, or in combination
with percutaneous drainage, was also effective in the
treatment of bilomas after HHD. We recommend the
use of percutaneous drainage combined with ES, if
possible.
The most common postoperative complication of
hepatic hydatid cyst surgery is external biliary fistulae.
Biliary fistulae occur in 4%-9% of cases. A persistent
external biliary fistula is defined as a fistula that
persists after the tenth postsurgery day. Although
spontaneous closure may occur, persistent biliary
fistulae are not infrequent (38). Bile leakage can
complicate the postoperative period in patients that
undergo surgery for HHD. It is reported that
postoperative biliary leakage significantly increases
postoperative complications (16); it significantly
increases the length of postoperative hospital stays, as
reported by Kayaalp (3), Demircan (16), and Atli (39)
(3,16,39). We were not able to compare the length of
hospital stays (LOS) between HHD patients with and
without biliary fistulae.
Development of a connection between the cyst
and the biliary tree is the main cause of fistulae. Cystic
growth into the liver parenchyma erodes the adjacent
bile duct and forms a communication between the
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cystic cavity and biliary tree. This connection makes
it possible for hydatid material to enter the biliary tree
or for bile to leak into the cyst. When there is
communication between the biliary tract and the
residual cyst cavity, bile may flow from the biliary tree
into the cystic cavity as a result of the pressure
gradient formed after surgery. This can be aggravated
by stenosis of the sphincter of Oddi or occlusion of
the CBD by hydatid material (38).
Some predictors of postoperative biliary fistulae
are described as follows: Demircan et al. reported that
ALP concentrations greater than 250 U L−1, a total
bilirubin level above 17.1 μmol L−1, direct bilirubin
above 6.8 μmol L−1, GGT higher than 34.5 U L−1, and
cyst size greater than 8.5 cm in the preoperative
period were independent predictors of occult CBC;
ALP was the most important (16). Atli et al. (39)
reported that elevated ALP and direct bilirubin were
risk factors for occult CBCs, and Kayaalp et al. (3)
reported that high ALP and GGT levels were risk
factors for CBCs (3,39). In the present study, 42
patients (42.4%) had normal levels of ALP, AST, ALT,
GGT, and bilirubin during the postoperative period.
The remaining 57 patients (57.5%) had elevated ALP
and GGT levels, while 21 of them (21.1%) had
elevated ALT, AST, and bilirubin levels. Our study was
not designed to identify the predictors of
postoperative biliary fistulae in patients undergoing
surgery for HHD and, therefore, we were unable to
compare the laboratory test results of the patients that
developed fistulae and non-complicated HHD
patients; however, the fact that 42.4% of patients with
postoperative biliary fistulae had normal liver
function test results is noteworthy.
Mean cyst diameter in this group was 8.6 ± 6.1 cm.
In 57 (57.5%) patients, the cyst associated with bile
leakage was larger than 10 cm. There was a positive
correlation between the size of the cysts and closure
time. Cyst diameter is suggested to be one of the
predictors of biliary leakage. Several authors reported
different cyst sizes as the cut-off point. While
Demircan et al. (16) reported that cysts larger than 8.5
cm were an independent predictor of occult CBC, Atli
et al. (39) reported that cysts 14.5 cm or greater in
diameter independently predicted occult intrabiliary
rupture. Bedirli et al. (15) observed a mean cyst
diameter of 9 cm in 41 patients with intrabiliary
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rupture. Among these researchers, a common finding
is that large cysts are associated with biliary leakage.
Yet Kayaalp et al. (13) reported that 65% of cysts that
caused biliary leakage were less than 10 cm. Kayaalp’s
findings closely resemble those of the present study; in
only 57.5% of patients with postoperative biliary
leakage, the cyst associated with the fistula was larger
than 10 cm. Kayaalp et al. (13) also stated that cystobiliary complications, biliary leakage, and biliary
fistulae were more common after resection in cysts
localized near the hilum (3,13,15,16,39).
In a retrospective review reported from our clinic,
Balik et al. (7) stated that postoperative biliary fistulae
commonly close spontaneously within 2-4 months. In
another series, spontaneous closure was reported to
occur within 38 days (40). Although spontaneous
closure may be expected, prolonged duration causes
significant morbidity. Thus, endoscopic intervention
is necessary.
The main aim of fistula treatment is to reduce
pressure in the biliary tree. This pressure is reported
to be less than 8-0 mm Hg (41,42). It is reported that
reducing the pressure gradient between the bile duct
and the duodenum, and diversion of bile away from
the site of the leak result in healing of fistulae (43).
This is provided by either surgical or endoscopic
means. Surgically, common bile duct exploration, ttube
drainage,
sphincteroplasty,
or
choledochoduodenostomy have frequently been
employed during HHD surgery to prevent the
development of biliary fistulae (44-46). These
operative treatment modalities for biliary fistulae after
HHD surgery are still used, but endoscopic
interventions are replacing them. Currently, the use
of ERCP is the gold standard for postoperative bile
leakage and cholangitis (2).
Endoscopic drainage can be performed by
endoscopic sphincterotomy (ES), nasobiliary drain,
or stent insertion. There are no guidelines that
definitely recommend when to choose ES, NBD, or
stenting. We routinely performed ES in our patients
with biliary leakage after HHD surgery. ES was also
performed before surgery in patients with suspected
CBCs.
Some reports recommend using only ES. ES is a
one-step procedure that is generally more familiar to
endoscopists, is less time consuming, and provides
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extraction of retained material (2). Yet ES has
limitations and is associated with complications,
including bleeding and perforation of the
sphincterotomy site. In our series we observed a few
complications, the majority of which was pancreatitis.
Bleeding occurred in only 1 patient and there was no
perforation. For persistent biliary fistulae ES was an
effective treatment in 94 (94.9%) patients in our
series; however, there was a need for repeat ERCP in
21 patients and there were patients with prolonged
fistulae (up to 2 months in 3 patients). Furthermore,
5 patients were operated on because endoscopic
treatment failed. Saritas et al. (47) reported that the
overall success rate of endoscopic treatment was 86%
and that a second surgical intervention was required
for only 6 of their patients. We think that repeat ERCP,
combined with the patience to observe prolonged
fistulae, can decrease the rate of surgical interventions
performed for postoperative biliary leakage.
Although NDB and stenting are less invasive
methods, ES is preferred by some surgeons in cases in
which cystic contents are present in the bile ducts
(48). Technically, a wide and satisfying ES can cause
displacement of a stent or NBD, but if the ES is not
wide enough it will not be possible to clear all the
cystic contents from the CBD. Thus, the endoscopist
must decide whether or not it is necessary to remove
the cystic contents from the CBD. The mechanism
that causes biliary complications of HHD depends
mostly on occlusion of the CBD by cystic contents;
therefore, it is more logical to remove these materials
and create a free flow for the bile. Furthermore, in
cases of Oddi stenosis, ES will provide a satisfactory
decrease in pressure. Rodriguez et al. (28) and Tekant
et al. (49) reported successful results using ES in their
patients (28,49). Our experience also suggests that ES
is safe and effective for the management of biliary
complications of HHD.
Ozaslan et al. (2) suggest the use of NBD, stating
various advantages (2). The introduction of the
catheter above the defect allows continuous aspiration
when the fistula originates at the level of the
intrahepatic biliary tract. NBD also decreases pressure
in the biliary tract, allows monitoring of fistulae by
cholangiography, and is appropriate for patients with
coagulopathy (2,43). The disadvantages of this
approach are that NBD is less comfortable for the
679
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Table 1.

Indications for ERCP (note that 3 patients underwent
ERCP both in the pre- and postoperative periods).

Indications

Preoperative
ERCP

Postoperative
ERCP

Cholangitis
Biloma
CBC or fistula

9
17

12
14
99

Total

26

125

patient, it can become displaced, and it can deprive
the patient of a significant proportion of their
intestinal bile (38,43). Cicek et al. (33) use NBD in
their patients more often than is usually reported in
the literature, and further suggest that NBD offers the
following additional advantages: NBD decreases
intraductal pressure more than ES or stenting, is more
convenient for following-up leak closure via repeat
cholangiograms, is more easy to remove after closure
of the leak, is useful during surgery for detecting small
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CBCs, and finally, is more useful when placed
preoperatively. Nonetheless, these reported
advantages should be investigated further, as we do
not agree that these are valid advantages. To begin
with, there is no evidence that NBD decreases
pressure in the CBD more than stenting or ES, except
when suction through the NBD is performed. Further,
the follow-up of leak closure can also be made
indirectly by observing drainage from the intracystic
drain or tube, and by collapsing the cystic cavity
during ultrasonography or tomography. When
performing ES it is unnecessary to remove anything;
rather than placing an NBD preoperatively and
making the patient uncomfortable, ES can be used as
an effective alternative. In our series, we observed that
ES did not effectively prevent biliary leakage in only 3
patients. Moreover, as mentioned above, Ozaslan et
al. (2) suggest that the most logical advantage of NBD
is the introduction of the catheter above the defect.
Yet, this is not always possible, and CBC may occur at
the terminal branches of the biliary tract. In such a

Table 2. Summary of cases that underwent preoperative ERCP.
Preoperative ERCP (26 patients)
Age

35.6 years (range: 12-67 years)

Number of cysts

32 (20 patients with 1 cyst, 6 patients with 2 cysts)

Cyst size

8.3 ± 4.1 cm (range: 3-16 cm), 20 cysts sized > 10 cm

Cyst Location

Right lobe

22 cysts

Left lobe

10 cysts

Cannulation success

100% (in 4 patients after the second attempt)

CBD diameter

6-38 mm

ERCP findings

Success of ERCP/ES

680

No positive findings

4 patients

Compression of the
biliary tract

2 patients

cystic contents,
germinative membranes,
and purulent material
in the CBD

20 patients

2 patients with cholangitis underwent emergency surgery,
3 patients had postoperative biliary fistulae
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Table 3. Summary of results of ERCP for postoperative biliary leakage.

ERCP for postoperative biliary leakage (99 patients)
Number of cysts
cysts)

119 (83 patients had 1 cyst, 12 patients had 2 cysts, 4 patients had 3

Cyst size

8.6 ± 6.1 cm

Cyst Location

Right lobe

18 cysts

Left lobe

101 cysts

Mean amount of daily drainage

475 ± 215 cc (range: 80-1400 cc)

Cannulation success

100%

CBD diameter

14.2 ± 5.4 mm (range: 6-28 mm)

ERCP findings

No positive findings

13 patients

Choledocholithiasis

1 patient

CBC

79 patients

cystic contents,
germinative membranes,
and purulent material
in the CBD

85 patients

Success of ERCP/ES

94.9%, (21 patients required a second and 9 a third ERCP/ES)

Decrease of biliary drainage after ERCP

2.4 days (range: 1- 18 days)

End of biliary drainage after ERCP

5.2 days (range: 2-57 days).

situation, an NBD can occlude the biliary tract. Based
on our study results, we conclude that the real
advantages of an NBD are in placing it preoperatively
for the detection of small CBCs, using it for fistulae at
the level of large biliary ducts, and when fistulae do
not respond to ES.

either incomplete evacuation of the CBD, or
obstruction caused by residual hydatid material or
unobserved stones (38). Bilsel et al. (27) placed stents
in 9 of their patients for the treatment of the biliary.
They stated that stenting is costly and may require
repeat ERCP for removal (27). Along with the costs
and the need for repeat ERCP, additional
disadvantages of stenting include stent displacement
and stricture formation (27). While we have not
implemented the use of stents, it can be noted that in
cases of overt CBC placement of a stent may be
preferred as an adjunctive therapy to ES (in chronic
and high output fistulae). Moreover, stents can be
used in patients with CBD narrowing due to various
issues (stricture formation, external compression).
Stents are used to provide a bridge over the ruptured

Stenting of the CBD for the treatment of biliary
fistulae was suggested by Akcakaya et al. (38). They
reported that biliary stenting is far superior to ES in
reducing CBD pressure. It has also been reported that
stenting will bypass the sphincter mechanism, which
in turn will advance fistula closure (50). Akcakaya et
al. (38) further reported that in 14 cases stenting
during the initial procedure decreased the fistula
closure time and increased the efficiency of ERCP.
They also reported that the reasons for failure were
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biliary mucosa and to provide epithelization. In their
experimental study concerning the comparison of
stenting and ES in cystic duct leaks, Marks et al.
reported that stenting more effectively reduces the
time to resolution of cystic duct leaks (51); however,
it is not the same as in hydatid disease because in
hydatid disease the main problem is obstruction of
the CBD with cystic contents. In contrast to postcholecystectomy fistulae, which close rapidly after ES,
and occasionally even close spontaneously, hydatid
fistulae are more resistant and rarely close
spontaneously without decompression of the biliary
tract (27). Thus, it is logical to use stents when there
is gross communication between the cyst and the bile
duct, especially when the duct is of a large diameter;
but, when communication exists at the level of the
terminal branches, stents are not useful and,
furthermore, can act as an obstruction. Moreover,
stents have to be changed after a period of time and
may also contribute to stricture formation in the
biliary tract. There is also need for repeat ERCP to
remove stents. Sharma et al. (43) reported that NBDs
and biliary stenting were equally effective in
promoting the healing of fistulae (43).
We preferred to use ES in all of our patients, as ES
was effective in resolving symptoms in most of our
patients. We conclude, therefore, that there is no need
for stenting or NBD insertion. Mean fistula closure
time was 5.2 days (range: 2-57 days) in the present
study. This time has been reported to range from 2
days to 43 days (21,26,27,29,44,47-49,52). Factors
influencing fistula closure were defined as time of the
ERCP, cyst diameter, and fistula output. Four
important factors in fistula healing are as follows: the
volume of bile produced by the biliary system above
the fistula, the size of the fistula, outflow pressure, and
the obstructive effects of the remaining hydatid
material or daughter cysts in the biliary tract (26,28).
Tekant et al. (49) reported that fistulae resolved
within 7 days; the present series had a longer
resolution time when compared with Tekant et al.’s
results (49). In contrast to Tekant et al. (49) most of
our patients underwent ERCP and ES for persistent
postoperative external biliary fistulae due to HHD.
Tekant et al. (49) reported that the fistulae in 10 of 11
patients that underwent ES resolved completely
within 7 days.
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There is no existing guideline regarding the timing
of endoscopic intervention. The timing of
intervention varies from a few days to several months
after surgery. Since persistent external biliary fistulae
are defined as those that persist after the tenth
postoperative day, it is logical that ERCP should be
performed after the tenth postoperative day. For our
purposes, we decided to wait until after the diagnosis
of a persistent fistula was confirmed before choosing
immediate endoscopic intervention (21,44,47,48,52).
Tekant et al. (49) reported a negative correlation
between fistula closure time (duration of the fistula)
and time elapsed until ERCP; therefore, they
recommend early ERCP and ES. Dolay et al. (48)
reported that the fistulae in their series closed within
1 month, within a median period of 10 days. They did
not find any correlations between the duration of the
fistulae, and their daily output and the duration of the
fistulae before ERCP (48). Dolay et al. (48) further
suggest that during the early postoperative period
spontaneous closure will not take place in cases with
high fistula output, and so early ERCP and ES should
be performed. Nonetheless, they do not provide a
definition of high fistula output (48). In the present
study the decision to perform ERCP was made by the
surgeon. There were patients in whom the procedure
was performed both early and late. Similar to the
findings reported by Tekant et al. (49), statistical
analysis in the present study revealed a negative
correlation between fistula closure time (duration of
the fistula) and the time to ERCP. We observed that a
shortened timeframe to endoscopic intervention
correlated with a short fistula closure time.
We evaluated the relationship between the size of
the cysts causing postoperative biliary fistulae, and
daily fistula output and closure time. There was a
positive correlation between cyst size and closure time
(P = 0.04, r = 0.4), but there was not a correlation
between cyst size and daily bile output (P < 0.05).
Interestingly, there was a positive correlation between
daily output and duration of closure time (P = 0.01, r
= 0.04).
In conclusion, we propose that ERCP and ES
should be the first choice of treatment for both the
pre- and postoperative biliary complications of HHD
(Figure 7). Preoperative use of ERCP and ES can
provide relief of symptoms, but hydatid lesions cannot
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Non-complicated HHD

Preoperative biliary
complications of HHD

ERCP/E
success

failure

Elective operation

Repeat ERCP or emergency
surgery

Postoperative biliary
fistula

Postoperative
cholangitis

Postoperative
biloma

With or without
percutaneous
drainage

ERCP/ES

failure

success

Repeat ERCP/ES and observe

failure

surgery

Figure 7. The proposed algorithm for the treatment of the biliary complications of HHD, based on our clinical experience.
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be treated without surgery. For postoperative
cholangitis and bilomas, ERCP and ES are effective.
In regard to bilomas specifically, combined treatment
with percutaneous drainage should be used. The
success rate of ERCP and ES for postoperative biliary
fistulae is high, although repeat ERCP is sometimes
necessary. After performing the first endoscopic
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intervention, a “wait and observe” period is necessary.
NBDs and stents can be used for large defects at the
level of large biliary ducts, but should not be used as
a first-line treatment because of their potential
disadvantages. Surgery should be the last choice for
the treatment of postoperative biliary leaks after
surgery for HHD.
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